Charles A. Herzog, MD, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: AstraZeneca Pharmaceuticals(SIGNIFICANT), Diamedica(MODEST), Janssen Pharmaceuticals, Inc(MODEST), NxStage(SIGNIFICANT), Pfizer(MODEST), Relypsa(SIGNIFICANT), Bayer(MODEST), Merck & Co., Inc.(MODEST) OWNERSHIP/PARTNERSHIP/PRINCIPAL: General Electric(MODEST), Merck(SIGNIFICANT), Boston Scientific(MODEST), Johnson & Johnson(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Amgen(SIGNIFICANT), Bristol-Myers Squibb Company (SIGNIFICANT), Relypsa(SIGNIFICANT) OTHER FINANCIAL BENEFIT: UpToDate(MODEST)

View Full Disclosure